Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury
用于治疗氯吸入损伤的先进 TRPA1 抑制剂
基本信息
- 批准号:10002221
- 负责人:
- 金额:$ 76.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcroleinAcuteAcute Lung InjuryAirway ResistanceAmericanAnimal ModelAntidotesArrhythmiaBloodBlood specimenBronchiolitis ObliteransCardiovascular systemCell CountCell Culture TechniquesChemical WeaponsChemicalsChlorineClinical TrialsConflict (Psychology)DevelopmentDoseDrug KineticsEdemaFamily suidaeFrequenciesFutureGasesGenerationsGoalsHistopathologyHumanIn VitroIndustrial AccidentsInfiltrationInflammationInhalationInjuryIntramuscularInvestigational TherapiesIon ChannelIrritantsLeukocytesLungLung InflammationMeasuresModelingMorbidity - disease rateMusNervous system structureNeurologic EffectOralOrganOxygenPainPartial PressurePhysiologicalPlasmaPreparationProcessPropertyProteinsProtocols documentationRecoveryRespiratory SystemRiotsRodentRouteSkin injurySupine PositionTerrorismTestingTherapeutic EffectTherapeutic StudiesTimeTissuesToxicologyTransportationTreatment EfficacyUnited StatesVasodilationVentilatorVesicantsWeightWhite Blood Cell Count procedureWorld War Ianimal ruleappropriate dosebasechlorine gascytokineeffective therapyefficacy testingimprovedin vivoindexinginhibitor/antagonistinjuredliquid chromatography mass spectrometrylung injurymedical countermeasuremethacholinemortalitymouse modelnerve supplypressurepreventprimary endpointpulmonary functionreceptorrespiratoryresponsesensorsevere injurystandard of caresymptom treatmenttherapeutic evaluationweapons
项目摘要
Summary
Chlorine gas has been used as a terrorist weapon, in warfare and has injured many Americans in
transportation or industrial accidents. Despite its devastating effects, no mechanism-based treatment has been
developed. In this application, we hypothesize that targeting the TRPA1 ion channel post-exposure will
ameliorate the acute pulmonary, cardiovascular and neurological effects of chlorine, leading to decreased
morbidity and improved recovery. TRPA1 is a chemical irritant receptor eliciting pain, edema, vasodilation,
cardiac arrhythmia, inflammation and leukocyte infiltration. Our preliminary studies in mice show that TRPA1
inhibitors, when administered post-chlorine exposure, prevent the chlorine-induced decline of blood
oxygenation, improve pulmonary function and mitigate inflammation.
Here, we propose to test the efficacy of a 3rd generation TRPA1 inhibitor, found to block mouse, human
and porcine TRPA1, in mouse and pig models of chlorine inhalation injury, with the goal to develop this
compound as a future human countermeasure. The following aims are proposed: Aim 1: Screen potential
therapeutic effects of a 3rd generation TRPA1 inhibitor in mouse models of Cl2 gas inhalation injury. Aim 2:
Determine the pharmacokinetic and toxicological properties of TRPA1 inhibitor in pigs. Aim 3: Test the TRPA1
inhibitor in a pig model of chlorine gas inhalation injury
摘要
氯气曾被用作恐怖分子的武器,用于战争,并在
交通或工业事故。尽管它有毁灭性的影响,但还没有任何基于机制的治疗方法
发展起来的。在本应用中,我们假设暴露后靶向TRPA1离子通道将
改善氯的急性肺、心血管和神经影响,导致
发病率和恢复率的提高。TRPA1是一种化学刺激性受体,可引起疼痛、浮肿、血管扩张、
心律失常、炎症和白细胞浸润。我们在小鼠身上的初步研究表明,TRPA1
氯气暴露后给药时,抑制剂可防止氯气引起的血液下降
氧合,改善肺功能,减轻炎症。
在这里,我们建议测试第三代TRPA1抑制剂的有效性,发现它可以阻断小鼠、人
以及猪的TRPA1,在小鼠和猪的氯气吸入损伤模型中,目的是开发这种
作为未来人类的一种对策。提出了以下目标:目标1:屏幕电位
第三代TRPA1抑制剂对小鼠Cl2气体吸入性损伤的治疗作用目标2:
测定TRPA1抑制剂在猪体内的药代动力学和毒理学特性。目标3:测试TRPA1
抑制剂在氯气吸入性损伤猪模型中的应用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Satyanarayana Achanta其他文献
Satyanarayana Achanta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Satyanarayana Achanta', 18)}}的其他基金
Discovery of phosgene and chlorine gas modes of action and therapeutic targets using chemoproteomic profiling strategies
使用化学蛋白质组学分析策略发现光气和氯气的作用模式和治疗靶点
- 批准号:
10883970 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Pulmonary cell fate and lung repair in rodent and porcine models of chlorine and phosgene inhalation injuries
氯和光气吸入损伤的啮齿动物和猪模型中的肺细胞命运和肺修复
- 批准号:
10506127 - 财政年份:2022
- 资助金额:
$ 76.98万 - 项目类别:
Inhibition of soluble epoxide hydrolase protects against phosgene-induced lung injuries
抑制可溶性环氧化物水解酶可预防光气引起的肺损伤
- 批准号:
10207055 - 财政年份:2021
- 资助金额:
$ 76.98万 - 项目类别:
Inhibition of soluble epoxide hydrolase protects against phosgene-induced lung injuries
抑制可溶性环氧化物水解酶可预防光气引起的肺损伤
- 批准号:
10464888 - 财政年份:2021
- 资助金额:
$ 76.98万 - 项目类别:
Specialized pro-resolving mediators as potential medical countermeasures in a pig model of chlorine gas-induced acute lung injury
专门的促解决介质作为氯气引起的急性肺损伤猪模型的潜在医学对策
- 批准号:
10153787 - 财政年份:2020
- 资助金额:
$ 76.98万 - 项目类别:
Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury
用于治疗氯吸入损伤的先进 TRPA1 抑制剂
- 批准号:
10247523 - 财政年份:2019
- 资助金额:
$ 76.98万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 76.98万 - 项目类别:
Fellowship














{{item.name}}会员




